RLYB - Rallybio Corporation Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.53 0.01 (1.44%)	---	---	---	0.0 (-0.02%)	0.0 (0.37%)	---	0.0 (-0.02%)

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.22
Diluted EPS:: -0.22
Basic P/E:: -2.4636
Diluted P/E:: -2.4636
RSI(14) 1m:: 69.14
VWAP:: 0.54
RVol:: 0.6513

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.53 -0.01 (-1.0%)	Oct 15 14:35
1m	Price increase 1m	0.55 +0.01 (+2.13%)	Oct 15 12:41
1m	Price decrease 1m	0.53 -0.01 (-1.55%)	Oct 15 12:08
10m	Price decrease 10m	0.53 -0.02 (-3.8%)	Oct 15 12:08
1m	Price decrease 1m	0.54 -0.01 (-1.21%)	Oct 15 11:09